Victory Capital Management Inc. boosted its stake in Clorox Co. (NYSE:CLX) by 4.2% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 9,967 shares of the company’s stock after buying an additional 400 shares during the period. Victory Capital Management Inc.’s holdings in Clorox were worth $1,379,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Checchi Capital Advisers LLC boosted its position in Clorox by 1.0% in the second quarter. Checchi Capital Advisers LLC now owns 820 shares of the company’s stock worth $113,000 after buying an additional 8 shares during the last quarter. Cleararc Capital Inc. boosted its position in Clorox by 0.3% in the first quarter. Cleararc Capital Inc. now owns 3,163 shares of the company’s stock worth $399,000 after buying an additional 10 shares during the last quarter. Mariner Wealth Advisors LLC boosted its position in Clorox by 0.4% in the first quarter. Mariner Wealth Advisors LLC now owns 2,505 shares of the company’s stock worth $316,000 after buying an additional 10 shares during the last quarter. Keel Point LLC boosted its position in Clorox by 0.5% in the second quarter. Keel Point LLC now owns 7,512 shares of the company’s stock worth $1,040,000 after buying an additional 37 shares during the last quarter. Finally, Moody Lynn & Lieberson LLC boosted its position in Clorox by 2.0% in the second quarter. Moody Lynn & Lieberson LLC now owns 2,037 shares of the company’s stock worth $282,000 after buying an additional 40 shares during the last quarter. 70.17% of the stock is currently owned by institutional investors and hedge funds.

Clorox Co. (NYSE:CLX) traded up 1.10% during mid-day trading on Tuesday, reaching $124.02. The company’s stock had a trading volume of 689,177 shares. The company has a market cap of $16.06 billion, a PE ratio of 25.21 and a beta of 0.33. The firm’s 50 day moving average is $129.73 and its 200-day moving average is $130.12. Clorox Co. has a 12-month low of $112.75 and a 12-month high of $140.47.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, August 3rd. The company reported $1.26 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.28 by $0.02. The company earned $1.60 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Clorox had a net margin of 11.25% and a return on equity of 296.91%. The company’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same quarter last year, the business posted $1.44 earnings per share. Equities analysts anticipate that Clorox Co. will post $5.49 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 14th. Shareholders of record on Wednesday, October 26th will be issued a dividend of $0.80 per share. This represents a $3.20 dividend on an annualized basis and a yield of 2.61%. The ex-dividend date of this dividend is Monday, October 24th. Clorox’s dividend payout ratio (DPR) is 64.91%.

CLX has been the topic of a number of analyst reports. Jefferies Group reaffirmed a “hold” rating on shares of Clorox in a research report on Wednesday, August 3rd. B. Riley reaffirmed a “neutral” rating and set a $109.00 price objective on shares of Clorox in a research report on Tuesday, August 9th. Atlantic Securities initiated coverage on Clorox in a research report on Tuesday, June 14th. They set a “neutral” rating and a $138.00 price objective on the stock. Deutsche Bank AG reaffirmed a “hold” rating and set a $134.00 price objective (up from $130.00) on shares of Clorox in a research report on Sunday, July 24th. Finally, Zacks Investment Research cut Clorox from a “hold” rating to a “sell” rating in a research report on Tuesday, July 5th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $128.90.

In other Clorox news, EVP Laura Stein sold 38,882 shares of Clorox stock in a transaction dated Friday, September 2nd. The stock was sold at an average price of $131.69, for a total transaction of $5,120,370.58. Following the completion of the sale, the executive vice president now directly owns 48,501 shares of the company’s stock, valued at approximately $6,387,096.69. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Dawn C. Willoughby sold 10,617 shares of Clorox stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $131.01, for a total value of $1,390,933.17. Following the sale, the chief operating officer now directly owns 20,353 shares of the company’s stock, valued at $2,666,446.53. The disclosure for this sale can be found here. Company insiders own 2.09% of the company’s stock.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

5 Day Chart for NYSE:CLX

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).

Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.